China's Sinovac COVID-19 Vaccine Is Less Than 60% Effective in Brazil Trial: Report

China's Sinovac COVID-19 Vaccine Is Less Than 60% Effective in Brazil Trial: Report

China's Sinovac COVID-19 vaccine was reported to have a general efficacy of less than 60 percent in its late-stage clinical trial in Brazil.
Most Read
  1. Tini Stoessel & Young Miko Aren't Hiding Anymore
  2. First Photos of Gisele Bündchen’s Baby Bump: A Cover-Worthy Mom-to-Be!
  3. The Best Places to Celebrate Halloween in the United States
  4. Tekashi 6ix9ine is Back in the Spotlight After Being Arrested Again—Will He Lose His Record Deal?
Real Time Analytics